R Squared Ltd Invests $297,000 in Encompass Health Co. (NYSE:EHC)

R Squared Ltd bought a new stake in Encompass Health Co. (NYSE:EHC) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 3,220 shares of the company’s stock, valued at approximately $297,000.

Several other institutional investors have also recently bought and sold shares of the company. KBC Group NV raised its holdings in shares of Encompass Health by 55.7% in the fourth quarter. KBC Group NV now owns 4,294 shares of the company’s stock valued at $397,000 after purchasing an additional 1,537 shares during the last quarter. Blue Trust Inc. increased its stake in Encompass Health by 1,019.1% in the 4th quarter. Blue Trust Inc. now owns 1,578 shares of the company’s stock valued at $152,000 after buying an additional 1,437 shares during the last quarter. First Citizens Bank & Trust Co. lifted its position in Encompass Health by 14.1% during the 4th quarter. First Citizens Bank & Trust Co. now owns 2,687 shares of the company’s stock worth $248,000 after buying an additional 332 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of Encompass Health by 17.4% during the 4th quarter. Janney Montgomery Scott LLC now owns 13,338 shares of the company’s stock worth $1,232,000 after buying an additional 1,981 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH grew its holdings in shares of Encompass Health by 0.3% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 302,272 shares of the company’s stock valued at $27,915,000 after acquiring an additional 830 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Royal Bank of Canada boosted their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. KeyCorp increased their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Truist Financial restated a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Up 0.4 %

EHC opened at $96.71 on Wednesday. The stock has a market cap of $9.74 billion, a PE ratio of 23.36, a price-to-earnings-growth ratio of 1.13 and a beta of 0.89. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a twelve month low of $70.74 and a twelve month high of $104.55. The company has a fifty day moving average of $96.63 and a 200-day moving average of $94.57.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the prior year, the business earned $0.86 EPS. The company’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, sell-side analysts predict that Encompass Health Co. will post 4.29 EPS for the current year.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.